Millipore Shares Soar on Rumors of a $6B Buyout Bid from Thermo Fisher | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Millipore climbed as high as $102.91 — a 44 percent rise from its Friday closing price of $71.34 — after a report from Bloomberg claimed that Thermo Fisher Scientific has made an unsolicited $6 billion bid to acquire the firm.

A Thermo Fisher spokesperson said the firm would not comment on the "rumor," and Millipore did not respond to a request for comment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.